ADMA Biologics Inc
ADMA
$9.83+4.80%
Delayed · as of Sep 28, 2026, 2:00 PM ET
Mkt cap
$4.39B
EV/Sales
8.58
P/E ratio
N/A
FY2025 Revenue
$510.17M
EPS (TTM)
$0.70
Gross Margin (FY2025)
57.39%
Profit Margin (FY2025)
28.80%
Beta
0.47
Div yield
N/A
Sector
Healthcare
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Latest reported ADMA revenue for 2025-12-31 was $510.2M. Net income was $146.9M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. ADMA currently screens at market cap $4.39B.
Use this ADMA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ADMA income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
ADMA Biologics Inc (ADMA) is a biotechnology company in the Healthcare sector.
Latest cached ADMA Biologics Inc (ADMA) revenue for Dec 31, 2025 was $510.2M. Net income was $146.9M. Statements: https://lician.com/financials/adma
ADMA Biologics Inc (ADMA) market capitalization is $4.39B on the latest cached snapshot.
ADMA Biologics Inc (ADMA) cached previous close $9.38; day range $9.25 – $9.95; volume 1,339,401. Session quote: https://lician.com/quote/adma
ADMA Biologics Inc (ADMA) latest cached earnings event is "ADMA earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ADMA filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/adma